North America Fertility Supplements Market Size, Share & Industry Trends Analysis Report By Ingredient, By End-Use (Women and Men), By Distribution Channel, By Product (Capsules, Tablets, Soft Gels, Powder, and Liquid), By Country and Growth Forecast, 2022 - 2028

The North America Fertility Supplements Market should witness market growth of 6.5% CAGR during the forecast period (2022-2028).

Foods like olive oil, avocados, whole grains, and high-fat milk products are increasingly used to boost fertility. A rise in the usage of herbal (or botanical) medications has also been witnessed due to consumer concern about the unfavorable side effects of traditional pharmaceutical drugs, which is advantageous for product makers.

Due to a number of initiatives aimed to increase knowledge of the advancements in supplement research consumers are nowadays more likely to pick supplements based on what works best for their well-being rather than appealing packaging and marketing. Nowadays, these medications also incorporate cutting-edge technology in their making, involving methods that would affect with most effectiveness.

Due to factors including the rising rate of infertility and rising public awareness of general health, North America is anticipated to experience considerable demand in the coming years. The CDC reported that 11% of women in the U. S. smoked. Additionally, the World Health Organization claims that infertility has become more widespread as a result of a variety of reasons. These include a rise in smoking, and alcohol consumption, the number of obese individuals, an increase in stress levels that lead to hormonal imbalances, and other things.

The US market dominated the North America Fertility Supplements Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $742.7 million by 2028. The Canada market is poised to grow at a CAGR of 8.5% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 8.3% during (2022-2028).

Based on Ingredient, the market is segmented into Synthetic/ Blend of Natural & Synthetic and Natural. Based on End-Use, the market is segmented into Women and Men. Based on Distribution Channel, the market is segmented into Over-the-counter and Prescribed. Based on Product, the market is segmented into Capsules, Tablets, Soft Gels, Powder, and Liquid. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Fairhaven Health, Coast Science LLC, LENUS Pharma GesmbH, CellOxess LLC, Orthomol pharmazeutische Vertriebs GmbH, Exeltis USA, Inc. (Grupo INSUD), Yad-Tech, Bionova Lifesciences (Pragati Biocare Pvt. Ltd.), Vitabiotics Ltd., and TTK Healthcare Limited.

Scope of the Study

By Ingredient

• Synthetic/ Blend of Natural & Synthetic
• Natural

By End-use

• Women
• Men

By Distribution Channel

• Over-the-counter
• Prescribed

By Product

• Capsules
• Tablets
• Soft Gels
• Powder
• Liquid

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Fairhaven Health
• Coast Science LLC
• LENUS Pharma GesmbH
• CellOxess LLC
• Orthomol pharmazeutische Vertriebs GmbH
• Exeltis USA, Inc. (Grupo INSUD)
• Yad-Tech
• Bionova Lifesciences (Pragati Biocare Pvt. Ltd.)
• Vitabiotics Ltd.
• TTK Healthcare Limited

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free